Immune Responses to RHAMM in Patients with Acute Myeloid Leukemia after Chemotherapy and Allogeneic Stem Cell Transplantation

In situ RHAMM protein expression in acute myeloid leukemia blasts suggests poor overall survival

(2011) Alexandar Tzankov et al.   ANNALS OF HEMATOLOGY

Clinical peptide vaccination trials for leukemia patients

(2011) R Casalegno-Garduño et al.   Expert Review of Vaccines

High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma

(2010) J. Greiner et al.   HAEMATOLOGICA

Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling

(2010) J. Chen et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8+ T-cell responses in patients with chronic lymphocytic leukemia

(2010) K Giannopoulos et al.   LEUKEMIA

Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8+ CD62L(high)+ T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rγnull mice

(2008) Eva Distler et al.   EXPERIMENTAL HEMATOLOGY

PR1 vaccination in myeloid malignancies

(2008) Katayoun Rezvani   Expert Review of Vaccines